Dysregulated expression of SKP2 and its role in hematological malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dysregulated expression of SKP2 and its role in hematological malignancies

Published:2017-08-10 Issue:5 Volume:59 Page:1051-1063
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kulinski Michal¹^ORCID,Achkar Iman W.¹^ORCID,Haris Mohammad²^ORCID,Dermime Said³^ORCID,Mohammad Ramzi M.¹,Uddin Shahab¹^ORCID

Affiliation:

1. Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar;

2. Translational Medicine Research Branch, Sidra Medical and Research Center, Doha, Qatar;

3. National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1359740

Reference134 articles.

1. The ubiquitin-proteasome proteolytic pathway

2. Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells

3. The proteasome: A worthwhile target for the treatment of solid tumours?

4. Ubiquitin ligases: cell-cycle control and cancer

5. Protein ubiquitination in lymphoid malignancies

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A patent review of SCF E3 ligases inhibitors for cancer：Structural design, pharmacological activities and structure–activity relationship;European Journal of Medicinal Chemistry;2024-11

2. Upregulated SKP2 Empowers Epidermal Proliferation Through Downregulation of P27 Kip1;Annals of Dermatology;2024

3. Neosetophomone B induces apoptosis in multiple myeloma cells via targeting of AKT/SKP2 signaling pathway;Cell Biology International;2023-10-26

4. Pan-Cancer Analysis of the Expression and Prognostic Value of S-Phase Kinase-Associated Protein 2;Open Access Macedonian Journal of Medical Sciences;2023-01-06

5. miR-590-5p Targets Skp2 to Inhibit the Growth and Invasion of Malignant Melanoma Cells;Disease Markers;2022-07-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3